Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 3/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/08

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 2months into anti-tuberculosis HR(H-Isoniazid, R-Rifampin) therapy.

Abundance in Group 1: increased abundance in TB +HRZ group - 2months into HR therapy(W12)

NCBI	Quality Control	Links
Akkermansia
Barnesiella
Prolixibacter
Alistipes
Desulfovibrio
Bifidobacterium
Anaerorhabdus
Parasutterella
Paraprevotella
Anaerosporobacter
Mucispirillum
Parvibacter
Pseudobacteroides
Olsenella
Thomasclavelia
Eggerthia

Revision editor(s): KateRasheed